All data are based on the daily closing price as of November 13, 2026
b

Boryung

003850.KO
6.61 USD
-0.06
-0.90%

Overview

Last close
6.61 usd
Market cap
539.94M usd
52 week high
7.38 usd
52 week low
5.19 usd
Target price
10.49 usd

Valuation

P/E
6.0179
Forward P/E
27.5482
Price/Sales
0.6805
Price/Book Value
0.8064
Enterprise Value
730.64M usd
EV/Revenue
0.9199
EV/EBITDA
4.682

Key financials

Revenue TTM
794.26M usd
Gross Profit TTM
290.18M usd
EBITDA TTM
89.98M usd
Earnings per Share
1.11 usd
Dividend
0.12 usd
Total assets
988.97M usd
Net debt
207.63M usd

About

Boryung Corporation engages in the manufacture and sale of pharmaceutical products in South Korea and internationally. It offers prescription drugs for hypertension, dyslipidemia, and diabetes drugs. The company was formerly known as Boryung Pharmaceutical Co., Ltd. and changed its name to Boryung Corporation in March 2022. Boryung Corporation was founded in 1957 and is headquartered in Seoul, South Korea.
  • Symbol
    003850.KO
  • Exchange
    KO
  • Isin
    KR7003850005
  • Country
    South Korea
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
    Mr. Jay Kim
  • Headquarter
    Seoul
  • Web site
    https://www.boryung.co.kr
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top